Cargando…

Dose-responses for mortality from cerebrovascular and heart diseases in atomic bomb survivors: 1950–2003

The scientific community faces important discussions on the validity of the linear no-threshold (LNT) model for radiation-associated cardiovascular diseases at low and moderate doses. In the present study, mortalities from cerebrovascular diseases (CeVD) and heart diseases from the latest data on at...

Descripción completa

Detalles Bibliográficos
Autores principales: Schöllnberger, Helmut, Eidemüller, Markus, Cullings, Harry M., Simonetto, Cristoforo, Neff, Frauke, Kaiser, Jan Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373359/
https://www.ncbi.nlm.nih.gov/pubmed/29222678
http://dx.doi.org/10.1007/s00411-017-0722-5
_version_ 1783394973576593408
author Schöllnberger, Helmut
Eidemüller, Markus
Cullings, Harry M.
Simonetto, Cristoforo
Neff, Frauke
Kaiser, Jan Christian
author_facet Schöllnberger, Helmut
Eidemüller, Markus
Cullings, Harry M.
Simonetto, Cristoforo
Neff, Frauke
Kaiser, Jan Christian
author_sort Schöllnberger, Helmut
collection PubMed
description The scientific community faces important discussions on the validity of the linear no-threshold (LNT) model for radiation-associated cardiovascular diseases at low and moderate doses. In the present study, mortalities from cerebrovascular diseases (CeVD) and heart diseases from the latest data on atomic bomb survivors were analyzed. The analysis was performed with several radio-biologically motivated linear and nonlinear dose–response models. For each detrimental health outcome one set of models was identified that all fitted the data about equally well. This set was used for multi-model inference (MMI), a statistical method of superposing different models to allow risk estimates to be based on several plausible dose–response models rather than just relying on a single model of choice. MMI provides a more accurate determination of the dose response and a more comprehensive characterization of uncertainties. It was found that for CeVD, the dose–response curve from MMI is located below the linear no-threshold model at low and medium doses (0–1.4 Gy). At higher doses MMI predicts a higher risk compared to the LNT model. A sublinear dose–response was also found for heart diseases (0–3 Gy). The analyses provide no conclusive answer to the question whether there is a radiation risk below 0.75 Gy for CeVD and 2.6 Gy for heart diseases. MMI suggests that the dose–response curves for CeVD and heart diseases in the Lifespan Study are sublinear at low and moderate doses. This has relevance for radiotherapy treatment planning and for international radiation protection practices in general. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00411-017-0722-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6373359
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-63733592019-03-15 Dose-responses for mortality from cerebrovascular and heart diseases in atomic bomb survivors: 1950–2003 Schöllnberger, Helmut Eidemüller, Markus Cullings, Harry M. Simonetto, Cristoforo Neff, Frauke Kaiser, Jan Christian Radiat Environ Biophys Original Article The scientific community faces important discussions on the validity of the linear no-threshold (LNT) model for radiation-associated cardiovascular diseases at low and moderate doses. In the present study, mortalities from cerebrovascular diseases (CeVD) and heart diseases from the latest data on atomic bomb survivors were analyzed. The analysis was performed with several radio-biologically motivated linear and nonlinear dose–response models. For each detrimental health outcome one set of models was identified that all fitted the data about equally well. This set was used for multi-model inference (MMI), a statistical method of superposing different models to allow risk estimates to be based on several plausible dose–response models rather than just relying on a single model of choice. MMI provides a more accurate determination of the dose response and a more comprehensive characterization of uncertainties. It was found that for CeVD, the dose–response curve from MMI is located below the linear no-threshold model at low and medium doses (0–1.4 Gy). At higher doses MMI predicts a higher risk compared to the LNT model. A sublinear dose–response was also found for heart diseases (0–3 Gy). The analyses provide no conclusive answer to the question whether there is a radiation risk below 0.75 Gy for CeVD and 2.6 Gy for heart diseases. MMI suggests that the dose–response curves for CeVD and heart diseases in the Lifespan Study are sublinear at low and moderate doses. This has relevance for radiotherapy treatment planning and for international radiation protection practices in general. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00411-017-0722-5) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-12-08 2018 /pmc/articles/PMC6373359/ /pubmed/29222678 http://dx.doi.org/10.1007/s00411-017-0722-5 Text en © The Author(s) 2017, corrected publication 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
spellingShingle Original Article
Schöllnberger, Helmut
Eidemüller, Markus
Cullings, Harry M.
Simonetto, Cristoforo
Neff, Frauke
Kaiser, Jan Christian
Dose-responses for mortality from cerebrovascular and heart diseases in atomic bomb survivors: 1950–2003
title Dose-responses for mortality from cerebrovascular and heart diseases in atomic bomb survivors: 1950–2003
title_full Dose-responses for mortality from cerebrovascular and heart diseases in atomic bomb survivors: 1950–2003
title_fullStr Dose-responses for mortality from cerebrovascular and heart diseases in atomic bomb survivors: 1950–2003
title_full_unstemmed Dose-responses for mortality from cerebrovascular and heart diseases in atomic bomb survivors: 1950–2003
title_short Dose-responses for mortality from cerebrovascular and heart diseases in atomic bomb survivors: 1950–2003
title_sort dose-responses for mortality from cerebrovascular and heart diseases in atomic bomb survivors: 1950–2003
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373359/
https://www.ncbi.nlm.nih.gov/pubmed/29222678
http://dx.doi.org/10.1007/s00411-017-0722-5
work_keys_str_mv AT schollnbergerhelmut doseresponsesformortalityfromcerebrovascularandheartdiseasesinatomicbombsurvivors19502003
AT eidemullermarkus doseresponsesformortalityfromcerebrovascularandheartdiseasesinatomicbombsurvivors19502003
AT cullingsharrym doseresponsesformortalityfromcerebrovascularandheartdiseasesinatomicbombsurvivors19502003
AT simonettocristoforo doseresponsesformortalityfromcerebrovascularandheartdiseasesinatomicbombsurvivors19502003
AT nefffrauke doseresponsesformortalityfromcerebrovascularandheartdiseasesinatomicbombsurvivors19502003
AT kaiserjanchristian doseresponsesformortalityfromcerebrovascularandheartdiseasesinatomicbombsurvivors19502003